Lobe Sciences (XCNQ:LOBE) COGS-to-Revenue : 0.00 (As of Aug. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Lobe Sciences COGS-to-Revenue?

Lobe Sciences's Cost of Goods Sold for the three months ended in Aug. 2024 was C$0.00 Mil. Its Revenue for the three months ended in Aug. 2024 was C$0.00 Mil.

Lobe Sciences's COGS to Revenue for the three months ended in Aug. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Lobe Sciences's Gross Margin % for the three months ended in Aug. 2024 was N/A%.

Lobe Sciences COGS-to-Revenue Historical Data

The historical data trend for Lobe Sciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lobe Sciences COGS-to-Revenue Chart

Lobe Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

COGS-to-Revenue

Get a 7-Day Free Trial

0.03

0.01

Lobe Sciences Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24
COGS-to-Revenue	Get a 7-Day Free Trial															0.03	0.01	-	-	-

Lobe Sciences COGS-to-Revenue Calculation

Lobe Sciences's COGS to Revenue for the fiscal year that ended in Aug. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.002	/	0.136
	=	0.01

Lobe Sciences's COGS to Revenue for the quarter that ended in Aug. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Lobe Sciences (XCNQ:LOBE) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Lobe Sciences's Gross Margin % for the three months ended in Aug. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Lobe Sciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lobe Sciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Lobe Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lobe Sciences Ltd (XCNQ:LOBE) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

LOBEF:USA 6YX0:Germany

Address

1199 West Hastings Street, Suite 1400, Vancouver, BC, CAN, V6E 3T5

Website

https://www.lobesciences.com

Lobe Sciences Ltd is a biopharmaceutical company committed to discovering and developing patient-focused medicines for orphan and rare diseases. It is engaged in drug research and development to improve brain and mental health and wellness. The company plans to commercialize a medical food named Altemia for the treatment of Sickle Cell Disease and has other drugs in pipeline such as L-130 Treatment for Chronic Cluster Headache, L-131 Treatment for Pediatric Anxiety and S-100 Treatment for Sickle Cell Disease.

Lobe Sciences Headlines

No Headlines